The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese Population

Figure 2

Kaplan–Meier survival analysis of disease recurrence-free survival of patients in the BRAF V600E-positive group (a, c, e) and the negative group (b, d, f), stratified by tumor size, ETE, and lateral LNM.

(a)

(b)

(c)

(d)

(e)

(f)